Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Lord, Abbett & Co Downsize URS Corp Stake

Lord, Abbett & Co: In a 13G filing with the SEC, investment manager Lord, Abbett & Co just reported a 4.5% stake in URS Corp (NYSE:URS), down by about one-fourth from its previous 13F filing. Lord-Abbett has a fairly large and diverse equity portfolio, and URS is up 37% year-to-date.


URS Corp showed a 4% increase in its revenues on year-over-year terms. The revenue of the company totaled $2.79 billion in the second quarter of 2013. The net income of the company also went up to $67.3 million, or $0.91 in diluted EPS, versus $53.6 million and $0.72 in diluted EPS reported in the same period of last year.

Among hedge funds, several disclosed ownership of shares of URS Corp. However, the largest stake is held by Jana Partners, managed by Barry Rosenstein, which owns 4.8 million shares. Jana Partners is followed by Larry Robbins’ Glenview Capital, which has a slightly smaller stake with 4.6 million. Other “hedgies” have even smaller positions, like David Einhorn’s Greenlight Capital with 1.1 million shares, or Richard S. Pzena’s Pzena Investment Management, which owns around 1 million shares of URS Corp.

Disclosure: none

Recommended Reading:

Hedge Fund Industry Returns Were Positive Last Month

Hedge Fund News: David Harding, Dan Loeb & Bill Ackman’s Smarter Bet

Billionaire Ken Griffin Just Took a Big Stake in Global Brass and Copper


Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!